RGENRepligen Corporation

$7B

Q4 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$187M+0.1% YoY

Gross Profit

$96M51.4% margin

Operating Income

$49M26.1% margin

Net Income

$49M26.1% margin

EPS (Diluted)

$0.85

QoQ Revenue Growth

-7.0%

Cash Flow

Operating Cash Flow

$62M

Free Cash Flow

$40M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$2.5B

Total Liabilities

$621M

Stockholders' Equity

$1.9B

Cash & Equivalents

$523M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$187M	$187M	+0.1%
Gross Profit	$96M	$104M	-8.1%
Operating Income	$49M	$37M	+30.5%
Net Income	$49M	$29M	+67.4%

Revenue Segments

Product

$187M100%

Royalty

$247,0000%

RGEN Q4 2022 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena